--(BUSINESS WIRE)-- Advaxis is a biotechnology company developing proprietary, live but attenuated Listeria monocytogenes (Listeria) vaccines that deliver engineered tumor antigens, which stimulate multiple, simultaneous immunological mechanisms to fight cancer. Our platform technology was developed by Dr. Yvonne Paterson at The University of Pennsylvania. Today, the Company has over nine (9) distinct, cancer-fighting constructs in various stages of development, directly and through strategic collaborations with such recognized sites of excellence as the City of Hope, the Roswell Park Cancer Institute, the National Cancer Institute, the University of Pittsburgh, Cancer Research – UK, the University of British Columbia and the Department of Homeland Security. Please visit the Company’s portals: advaxis.com | facebook | twitter | LinkedIn
|
Company: |
Advaxis Incorporated | |||||||
|
Headquarters Address: |
305 College Road East | |||||||
| Princeton, NJ 08540 | ||||||||
|
Main Telephone: |
609.452.9813 | |||||||
|
Website: |
||||||||
|
Ticker: |
ADXS(OTCBB) |
|||||||
|
Type of Organization: |
Public | |||||||
|
Industry: |
Biotechnology | |||||||
|
Key Executives: |
Chairman: Thomas A Moore |
|||||||
|
CFO: Mark J Rosenblum |
||||||||
|
Executive Director: Conrad F Mir |
||||||||
|
Business Development |
||||||||
|
Contact: |
Conrad Mir | |||||||
|
Phone: |
609.452.9813 | |||||||
|
Email: |
||||||||
KEYWORDS: United States North America New Jersey
INDUSTRY KEYWORDS: Health Biotechnology Oncology Pharmaceutical Other Health
MEDIA:
| Logo |